Oliver R. Baumann is a passionate entrepreneur and has a track record of 17 years of experience in the area of investment banking, capital market strategies and life science. From 2003 – 2010, he was working at Credit Suisse in diverse positions and focused on alternative investments, research in the area of biotech and medtech as well as advisory of institutional clients. He advised diverse start-ups and M&A transactions. From 2010 – 2019, he was Head Alternative Strategies and Trading, and subsequently CEO and Partner of Sloan Asset Management/Belvoir Capital. Additionally, he is a member of several Boards of Directors.